BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17928955)

  • 1. Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.
    Hoelzinger DB; Nakada M; Demuth T; Rosensteel T; Reavie LB; Berens ME
    J Neurooncol; 2008 Feb; 86(3):297-309. PubMed ID: 17928955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.
    Ptaszynska MM; Pendrak ML; Stracke ML; Roberts DD
    Mol Cancer Res; 2010 Mar; 8(3):309-21. PubMed ID: 20197381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis.
    Li S; Wang B; Xu Y; Zhang J
    Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation.
    Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM
    Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.
    Zhang R; Wang J; Ma S; Huang Z; Zhang G
    BMC Cell Biol; 2011 Mar; 12():11. PubMed ID: 21406114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
    Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
    Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel point mutations attenuate autotaxin activity.
    Koh E; Bandle RW; Roberts DD; Stracke ML; Clair T
    Lipids Health Dis; 2009 Feb; 8():4. PubMed ID: 19222837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
    Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
    Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATX expression and LPA signalling are vital for the development of the nervous system.
    Fotopoulou S; Oikonomou N; Grigorieva E; Nikitopoulou I; Paparountas T; Thanassopoulou A; Zhao Z; Xu Y; Kontoyiannis DL; Remboutsika E; Aidinis V
    Dev Biol; 2010 Mar; 339(2):451-64. PubMed ID: 20079728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, regulation and function of autotaxin in thyroid carcinomas.
    Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
    Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
    Liu S; Umezu-Goto M; Murph M; Lu Y; Liu W; Zhang F; Yu S; Stephens LC; Cui X; Murrow G; Coombes K; Muller W; Hung MC; Perou CM; Lee AV; Fang X; Mills GB
    Cancer Cell; 2009 Jun; 15(6):539-50. PubMed ID: 19477432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
    Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
    Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
    Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
    J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.
    Ptaszynska MM; Pendrak ML; Bandle RW; Stracke ML; Roberts DD
    Mol Cancer Res; 2008 Mar; 6(3):352-63. PubMed ID: 18337445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.
    Wu JM; Xu Y; Skill NJ; Sheng H; Zhao Z; Yu M; Saxena R; Maluccio MA
    Mol Cancer; 2010 Mar; 9():71. PubMed ID: 20356387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.